نتایج جستجو برای: anthracyclines

تعداد نتایج: 3200  

2010
Nuhad K Ibrahim

The epothilone analog ixabepilone exhibits reduced susceptibility to several important tumor survival mechanisms that limit the efficacy of taxanes and anthracyclines. As a single agent, ixabepilone has shown promise in metastatic breast cancer when anthracyclines, taxanes, or capecitabine have failed; and in early-stage breast cancer that is taxane-naïve or has previously received taxanes in t...

Journal: :Molecular cancer therapeutics 2007
Suzanne M Cutts Lonnie P Swift Vinochani Pillay Robert A Forrest Abraham Nudelman Ada Rephaeli Don R Phillips

The anthracycline group of compounds is extensively used in current cancer chemotherapy regimens and is classified as topoisomerase II inhibitor. However, previous work has shown that doxorubicin can be activated to form DNA adducts in the presence of formaldehyde-releasing prodrugs and that this leads to apoptosis independently of topoisomerase II-mediated damage. To determine which anthracycl...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2006
A Avilés N Neri M J Nambo

BACKGROUND The use of anthracyclines in patients with cancer has been associated with the presence, even when standard doses were employed, of cardiac toxicity, most frequently after 5 years of therapy. Treatment of cancer during pregnancy remains a dilemma because cytotoxic therapy has been associated with the presence of severe side-effects. The outcome of children that received antracyclines...

Journal: :Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 2014
Maria Daskalaki Thomas Makris Theodore Vassilakopoulos Ioannis Moyssakis Marina Siakantaris Maria Angelopoulou Dimitrios Papadogiannis George Vaiopoulos Gerasimos Pangalis

INTRODUCTION Anthracyclines have been widely used in the treatment of haematological malignancies. Their major adverse effect is cardiomyopathy, but their effect on vascular elasticity has not been completely elucidated. The aim of the present study was to investigate the effects of anthracyclines on aortic elastic properties in patients with lymphomas. METHODS We studied 70 patients with lym...

Journal: :Molecular pharmacology 2014
Dong Gui Hu Anne Rogers Peter I Mackenzie

Anthracyclines are effective genotoxic anticancer drugs for treating human malignancies; however, their clinical use is limited by tumor resistance and severe cardiotoxicity (e.g., congestive heart failure). Epirubicin (EPI) is less cardiotoxic compared with other canonical anthracyclines (e.g., doxorubicin). This has been attributed to its unique glucuronidation detoxification pathway. EPI is ...

Journal: :Cancer research 1979
M Inaba H Kobayashi Y Sakurai R K Johnson

Significantly decreased uptake and retention of daunorubicin (DAU) and Adriamycin (ADR) have been reported in sublines of P388 leukemia resistant to these anthracyclines. We studied the effects of inhibitors of oxidative phosphorylation on uptake and retention of DAU and ADR in order to characterize the transport process for these anthracyclines and to clarify further the alteration in resistan...

2013
Mina Mhallem Gziri Peter Pokreisz Rita De Vos Eric Verbeken Frédéric Debiève Luc Mertens Stefan P. Janssens Frédéric Amant

Anthracyclines are used to treat cancers during the second and third trimester of pregnancy. The chemotherapeutic effect of anthracyclines is associated with a doseand time-dependent cardiotoxicity that is well described for infants and adults. However, data regarding fetal anthracycline-related cardiotoxicity after administration of chemotherapeutics during pregnancy are limited. In this study...

Journal: :The American journal of cardiology 2011
Heloisa Sawaya Igal A Sebag Juan Carlos Plana James L Januzzi Bonnie Ky Victor Cohen Sucheta Gosavi Joseph R Carver Susan E Wiegers Randolph P Martin Michael H Picard Robert E Gerszten Elkan F Halpern Jonathan Passeri Irene Kuter Marielle Scherrer-Crosbie

As breast cancer survival increases, cardiotoxicity associated with chemotherapeutic regimens such as anthracyclines and trastuzumab becomes a more significant issue. Assessment of the left ventricular (LV) ejection fraction fails to detect subtle alterations in LV function. The objective of this study was to evaluate whether more sensitive echocardiographic measurements and biomarkers could pr...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید